KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Rigel Pharmaceuticals (RIGL) Tax Provisions (2021 - 2025)

Historic Tax Provisions for Rigel Pharmaceuticals (RIGL) over the last 4 years, with Q3 2025 value amounting to -$280000.0.

  • Rigel Pharmaceuticals' Tax Provisions changed N/A to -$280000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $1.1 million, marking a year-over-year change of. This contributed to the annual value of $900000.0 for FY2024, which is N/A changed from last year.
  • Per Rigel Pharmaceuticals' latest filing, its Tax Provisions stood at -$280000.0 for Q3 2025.
  • In the past 5 years, Rigel Pharmaceuticals' Tax Provisions registered a high of $1.8 million during Q1 2021, and its lowest value of -$1.0 million during Q2 2021.
  • Its 3-year average for Tax Provisions is $207250.0, with a median of $2500.0 in 2021.